Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma

doi:10.3748/wjg.v16.i35.4410

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 35

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7560)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

653

HTML

6393

Figures (1-5)

306

Tables (1-1)

208

Sum=7560

Sep 21, 2010 (publication date) through Nov 4, 2024

Times Cited of This Article

Times Cited (82)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Sep 21, 2010; 16(35): 4410-4415
Published online Sep 21, 2010. doi: 10.3748/wjg.v16.i35.4410

Full Size Figure Download Figure

Figure 1 Serum α-fetoprotein levels in 107 patients with liver cirrhosis or hepatocellular carcinoma at late Barcelona Clinic Liver Cancer stages (A) and early Barcelona Clinic Liver Cancer stages (B). Each dot represents one patient. AFP: α-fetoprotein; HCC: Hepatocellular carcinoma; BCLC: Barcelona Clinic Liver Cancer.

Citation: Liu H, Li P, Zhai Y, Qu CF, Zhang LJ, Tan YF, Li N, Ding HG. Diagnostic value of glypican-3 in serum and liver for primary hepatocellular carcinoma. World J Gastroenterol 2010; 16(35): 4410-4415
URL: https://www.wjgnet.com/1007-9327/full/v16/i35/4410.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i35.4410